A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck

Autor: Mesía, Ricard, Vázquez, Silvia, Grau, Juan J., García-Sáenz, Jose A., Lozano, Alicia, García, Carlos, Carles, Joan, Irigoyen, Antonio, Mañós, Manel, García-Paredes, Beatriz, del Barco, Elvira, Taberna, Miren, Escobar, Yolanda, Cruz, Juan J.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 February 2016 94(2):289-296
Databáze: ScienceDirect